Cytophenix Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Seed
  • (Upcoming)

  • Latest Deal Amount
  • $3.27M

  • Investors
  • 4

Cytophenix General Information

Description

Operator of an AI-enhanced antimicrobial susceptibility testing system intended to provide rapid results to clinicians treating bacterial infections. The company offers AI-based testing and antimicrobial response analysis, enabling healthcare providers to identify effective treatments more quickly and support clinical decision-making for patients with serious infections.

Contact Information

Website
www.cytophenix.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Perth, Western Australia
  • Australia
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
LOHAS & Wellness, Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • Perth, Western Australia
  • Australia

Cytophenix Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytophenix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round $3.27M Upcoming Generating Revenue
4. Seed Round 29-Oct-2025 Completed Startup
3. Accelerator/Incubator 11-Sep-2024 Completed Generating Revenue
2. Accelerator/Incubator 06-Jun-2024 Completed Startup
1. University Spin-Out 01-Jan-2023 Completed Startup
To view Cytophenix’s complete valuation and funding history, request access »

Cytophenix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cytophenix Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
La Ferla Ventures Venture Capital Minority
Brandon Biocatalyst Venture Capital Minority
CSIRO ON Accelerate Accelerator/Incubator
The University of Western Australia University
To view Cytophenix’s complete investors history, request access »

Ready to get started?

Request a free trial

Cytophenix FAQs

  • When was Cytophenix founded?

    Cytophenix was founded in 2023.

  • Where is Cytophenix headquartered?

    Cytophenix is headquartered in Perth, Australia.

  • What is the size of Cytophenix?

    Cytophenix has 9 total employees.

  • What industry is Cytophenix in?

    Cytophenix’s primary industry is Laboratory Services (Healthcare).

  • Is Cytophenix a private or public company?

    Cytophenix is a Private company.

  • What is Cytophenix’s current revenue?

    The current revenue for Cytophenix is .

  • How much funding has Cytophenix raised over time?

    Cytophenix has raised $1.86M.

  • Who are Cytophenix’s investors?

    La Ferla Ventures, Brandon Biocatalyst, CSIRO ON Accelerate, and The University of Western Australia have invested in Cytophenix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process